Yi-Fei Hou
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yi-Fei Hou has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
Chao Yao
School of Basic Medical Science, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China
1 shared publicationChen-Yuan Gong
School of Basic Medical Science, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China
1 shared publication- Chunpu Zou
School of Basic Medical Science, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China
1 shared publication - Fei Zhang
Department of General Surgery, Xinhua Hospital affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
1 shared publication - Hong-Zhuan Chen
Shuguang Lab of Future Health, Shanghai Frontiers Science Center of TCM Chemical Biology, Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China
1 shared publication - Jianrong Xu
The Research Center for Traditional Chinese Medicine, Shanghai Institute of Infectious Diseases and Biosecurity, School of Integrative Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China
1 shared publication
Latest Publications
- 15 February 2026
- Published by Elsevier in Phytomedicine
- Vol. 153, 157981
Scopoletin alleviates cognitive deficits in 5xFAD mice via suppressing microglial inflammatory response
- 15 February 2026
- Published by Elsevier in Phytomedicine
- Vol. 153, 157981
Scopoletin alleviates cognitive deficits in 5xFAD mice via suppressing microglial inflammatory response
- Open Access
- 1 January 2021
- Published by Wiley in Mediators of Inflammation
- Vol. 2021 (1)
Ze‐Qi‐Tang Formula Induces Granulocytic Myeloid‐Derived Suppressor Cell Apoptosis via STAT3/S100A9/Bcl‐2/Caspase‐3 Signaling to Prolong the Survival of Mice with Orthotopic Lung Cancer
Non‐small‐cell lung cancer (NSCLC) remains the most common malignancy with the highest morbidity and mortality worldwide. In our previous study, we found that a classic traditional Chinese medicine (TCM) formula Ze‐Qi‐Tang (ZQT), which has been used in the treatment of respiratory diseases for thousands of years, could directly inhibit the growth of human NSCLC cells via the p53 signaling pathway. In this study, we explored the immunomodulatory functions of ZQT. We found that ZQT significantly prolonged the survival of orthotopic lung cancer model mice by modulating the tumor microenvironment (TME). ZQT remarkably reduced the number of MDSCs (especially G‐MDSCs) and inhibited their immunosuppressive activity by inducing apoptosis in these cells via the STAT3/S100A9/Bcl‐2/caspase‐3 signaling pathway. When G‐MDSCs were depleted, the survival promotion effect of ZQT and its inhibitory effect on lung luminescence signal disappeared in tumor‐bearing mice. This is the first study to illustrate the immunomodulatory effect of ZQT in NSCLC and the underlying molecular mechanism.
- 1 January 2021
- Published by Wiley in Mediators of Inflammation
- Vol. 2021 (1)
Open AccessZe‐Qi‐Tang Formula Induces Granulocytic Myeloid‐Derived Suppressor Cell Apoptosis via STAT3/S100A9/Bcl‐2/Caspase‐3 Signaling to Prolong the Survival of Mice with Orthotopic Lung Cancer
Non‐small‐cell lung cancer (NSCLC) remains the most common malignancy with the highest morbidity and mortality worldwide. In our previous study, we found that a classic traditional Chinese medicine (TCM) formula Ze‐Qi‐Tang (ZQT), which has been used in the treatment of respiratory diseases for thousands of years, could directly inhibit the growth of human NSCLC cells via the p53 signaling pathway. In this study, we explored the immunomodulatory functions of ZQT. We found that ZQT significantly prolonged the survival of orthotopic lung cancer model mice by modulating the tumor microenvironment (TME). ZQT remarkably reduced the number of MDSCs (especially G‐MDSCs) and inhibited their immunosuppressive activity by inducing apoptosis in these cells via the STAT3/S100A9/Bcl‐2/caspase‐3 signaling pathway. When G‐MDSCs were depleted, the survival promotion effect of ZQT and its inhibitory effect on lung luminescence signal disappeared in tumor‐bearing mice. This is the first study to illustrate the immunomodulatory effect of ZQT in NSCLC and the underlying molecular mechanism.